Product Image

Ginkgo with Vinpocetine

Swanson Superior Herbs
4.8
★ ★ ★ ★ ★
(714 ratings)
Vinpocetine 10 mg
Ginkgo
Product Image
Score79
A low-cost, focused ginkgo-and-vinpocetine blend with good dose clarity for vinpocetine but incomplete ginkgo standardization.
How scoring works
Quantity:60 Capsule(s) • (30 servings)
Goals:
Productivity Boost
Mental Focus
Brain Health
Vision Support

Score 79

A low-cost, focused ginkgo-and-vinpocetine blend with good dose clarity for vinpocetine but incomplete ginkgo standardization.
How scoring works
$9.19($0.30 per serving)
iHerb
$ 9.19
iHerb
$ 9.19
Amazon
$ 225.00
Report prices

Analysis

Ginkgo and vinpocetine form a logical pairing for blood-flow-related mental focus. Vinpocetine is clearly dosed, while ginkgo names flavone glycosides and terpene lactones without stating their actual percentages.

The ginkgo amount is better suited to mild maintenance than a stronger clinically standardized program. No additional memory or stress-resilience ingredients broaden the mechanism, which keeps the formula simple but narrow.

Two capsules provide the serving at an attractive cost. The main purchasing decision is whether the circulation-focused benefits justify the medication and pregnancy restrictions.

Who is it for
  • Adults seeking circulation-oriented cognitive support
  • People wanting a simple two-ingredient nootropic
Best for
  • Mental focus support
  • Productivity-oriented routines
  • Value-conscious vinpocetine use

Pros

  • Clearly stated vinpocetine amount
  • Names both major ginkgo marker classes
  • Focused formula
  • Competitive serving cost

Cons

  • Ginkgo marker percentages are absent
  • Ginkgo amount is maintenance-level
  • Requires two capsules
  • Limited pathway breadth

Warnings

  • Ginkgo and vinpocetine may add to anticoagulant or antiplatelet effects, increasing bruising or bleeding risk.
  • Stop the product before a planned procedure according to the surgeon’s instructions because ginkgo can affect bleeding.
  • Vinpocetine should not be used during pregnancy or when pregnancy is possible.

Nutrient quality

78 High impact

Ginkgo marker classes are named, but their percentages are not supplied. Vinpocetine is meaningfully dosed, while ginkgo sits closer to a modest maintenance amount, and ginkgo and vinpocetine create a focused cerebral-circulation formula.

.

Ingredient transparency

82 Highest impact

Every listed active has a specific amount and no proprietary blend obscures the formula. Complete intake directions and inactive ingredients are not supplied, leaving part of the label unverified.

.

Customer satisfaction

72 High impact

The supplied aggregate satisfaction level is exceptionally strong. The large feedback volume provides a dependable aggregate.

.

Value for money

84 Highest impact

The low cost is supported by a concise formula with a useful vinpocetine amount. The serving provides good value for the disclosed actives, and the formula appears competitive among simple ginkgo and vinpocetine combinations.

.
Report analysis

Goals

Productivity Boost
Productivity Boost
Impact
High effect
B Goal FitB- Strength of SupportC- CoverageA- Formula Quality
Vinpocetine · 10 mg

Ginkgo and vinpocetine both target cerebral circulation and may support processing during demanding work. Human evidence for productivity is modest, and the ginkgo lacks the marker percentages used in stronger research.

Vinpocetine reaches a standard amount, while ginkgo is closer to maintenance exposure. Ginkgo may increase bleeding risk with anticoagulant or antiplatelet medicines.

Study evidence
Ginkgo Supportive 20 studies
Ginkgo Supportive 12 studies
Mental Focus
Mental Focus
Impact
High effect
B- Goal FitB Strength of SupportD CoverageA Formula Quality

Ginkgo and vinpocetine create a coherent circulation-based approach to mental clarity. Vinpocetine is meaningfully dosed at 10 mg, while the 80 mg ginkgo amount is below many studied daily intakes.

The combination offers reasonable depth for cerebral circulation but does not address alertness, neurotransmitter synthesis, or stress resilience. Ginkgo and vinpocetine may add to bleeding risk, while vinpocetine may also lower blood pressure and should not be used during pregnancy.

Study evidence
Ginkgo Supportive 28 studies
Vinpocetine Supportive 3 studies
Brain Health
Brain Health
Impact
Moderate effect
C Goal FitC Strength of SupportD CoverageC+ Formula Quality

Ginkgo and vinpocetine target cerebral circulation, which may support cognition in selected users. The vinpocetine amount is useful, while ginkgo standardization and active yield remain unclear.

Both ingredients emphasize the same circulation pathway instead of covering memory formation, membrane health, or cerebral energy. Vinpocetine should be avoided during pregnancy, and ginkgo can increase bleeding risk with anticoagulant or antiplatelet medicines.

Study evidence
Ginkgo Supportive 90 studies
Vinpocetine Supportive 7 studies
Vision Support
Vision Support
Impact
Moderate effect
D Goal FitC+ Strength of SupportD CoverageB+ Formula Quality

Ginkgo and vinpocetine may support ocular circulation, but neither supplies structural retinal nutrients or macular pigments. Vinpocetine has particularly limited direct evidence for visual outcomes.

The amounts are clearly disclosed and reach practical levels for a circulation-focused combination. Missing ginkgo standardization percentages and purity details limit confidence in extract quality.

Study evidence
Ginkgo Supportive 11 studies
Vinpocetine Supportive 1 study

Ingredients

IngredientAmount per serving
Ginkgo biloba leaf extract (Flavone Glycosides, Terpene Lactones)
 80 mg
Vinpocetine (Periwinkle plant)
 10 mg
Adults 18–50
Report overview
Vinpocetine (Periwinkle plant) · 10 mg OverallScore86
A- Active Ingredient Quality & BioavailabilityA Dose, Safety & Label TransparencyB- Value

The 10 mg vinpocetine dose is clearly disclosed and paired with ginkgo extracts that may broaden cognitive support. Reaching the full serving requires two capsules, making daily use less streamlined than a single-unit option. The combination provides reasonable value for a multi-ingredient formula, while missing inactive-ingredient details leave excipient quality uncertain.

View ingredientView products
Ginkgo (Flavone Glycosides, Terpene Lactones) · 80 mg OverallScore40
F Active Ingredient Quality & BioavailabilityB+ Dose, Safety & Label TransparencyF Value

The extract names both active-marker classes but omits their percentages and any purity guarantee. The fully disclosed daily amount fits mild maintenance rather than the preferred clinical range. Cost appears moderate, but incomplete standardization limits confidence in value.

View ingredientView products
Loading alternative details
82 Performance

Herbal Extract Memory Complex

Swanson Ultra
<p>For a stronger fit within the relevant ingredient pathway, the compact blend covers circulation and cholinergic pathways with useful ginkgo and vinpocetine amounts. It adds a Huperzia pathway beyond the original; unstated ginkgo standardization and huperzine yield leave important potency uncertainty.</p>
84 Performance

Ginkgo Biloba 120 mg

California Gold Nutrition EuroHerbs
<p>For a stronger fit within the relevant ingredient pathway, the extract amount fits common daily use and names both key marker groups. It does not replace vinpocetine; missing marker percentages and a purity guarantee are the main limitations, while the supply delivers strong value.</p>
84 Performance

Ginkgo Biloba Phytosome 60 mg

Natural Factors HerbalFactors
<p>For a stronger fit within the relevant ingredient pathway, a recognized phytosome extract provides strong quality and absorption support. It does not replace vinpocetine; ginkgo may increase bleeding risk with anticoagulant or antiplatelet medicines.</p>
83 Budget

Ginkgo Biloba 60 mg

NOW
<p>At a lower serving cost than the original, the formula combines a maintenance extract with additional ginkgo leaf powder and names both key marker groups. It does not replace vinpocetine; missing marker percentages limit standardization confidence, but the very long supply provides excellent value.</p>
84 Budget

Ginkgo Biloba Certified Extract 120 mg

Life Extension
<p>At a lower serving cost than the original, named active-marker groups and a very low ginkgolic-acid limit provide strong purity assurance. It does not replace vinpocetine; ginkgo may increase bleeding risk with anticoagulant or antiplatelet medicines.</p>
83 Budget

Vinpocetine 10 mg

Source Naturals
<p>At a lower serving cost than the original, vinpocetine is a defined active compound that does not require a special nutrient salt form. It does not replace ginkgo; vinpocetine may lower blood pressure or affect clotting with antihypertensive, anticoagulant, or antiplatelet medicines.</p>
84 Value

Ginkgo Biloba 120 mg

Nature's Bounty
<p>For a more favorable quality-to-cost balance, the extract amount fits common daily use and names the two key ginkgo marker groups. It does not replace vinpocetine; missing marker percentages and purity limits reduce confidence despite excellent practical value.</p>
83 Value

Vinpocetine 10 mg

Source Naturals
<p>For a more favorable quality-to-cost balance, vinpocetine is a defined active compound that does not require a special nutrient salt form. It does not replace ginkgo; vinpocetine may lower blood pressure or affect clotting with antihypertensive, anticoagulant, or antiplatelet medicines.</p>
81 Value

Extra Strength Ginkgo 120 mg

Doctor's Best
<p>For a more favorable quality-to-cost balance, the key ginkgo marker groups are named, but their percentages and a purity limit are not fully disclosed. It does not replace vinpocetine; ginkgo may increase bleeding risk with anticoagulant or antiplatelet medicines.</p>
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Is Ginkgo biloba a cognitive enhancer in healthy individuals? A meta-analysis.
    Laws KR; Sweetnam H; Kondel TK · Human psychopharmacology · 2014
    Meta-analysis1,132 participants13 studies pooledMental Focus forGinkgo
  2. Ginkgo biloba: no robust effect on cognitive abilities or mood in healthy young or older adults.
    Burns NR; Bryan J; Nettelbeck T · Human psychopharmacology · 2006
    Randomized trial197 participantsMental Focus forGinkgo
  3. Psychopharmacological effects of vinpocetine in normal healthy volunteers.
    Subhan Z; Hindmarch I · European journal of clinical pharmacology · 1985
    Randomized trial12 participantsMental Focus forVinpocetine
  4. Effect of vinpocetine (cognitol™) on cognitive performances of a nigerian population.
    Ogunrin A · Annals of medical and health sciences research · 2014
    Non-randomized trial112 participantsMental Focus Brain Health forVinpocetine
  5. Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
    Tan MS; Yu JT; Tan CC; Wang HF; Meng XF; Wang C; Jiang T; Zhu XC; Tan L · Journal of Alzheimer's disease : JAD · 2015
    Meta-analysis2,561 participants9 studies pooledBrain Health forGinkgo
  6. Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
    von Gunten A; Schlaefke S; Überla K · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2017
    Meta-analysis1,628 participants4 studies pooledBrain Health forGinkgo
  7. Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
    Riepe M; Hoerr R; Schlaefke S · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2025
    Meta-analysis782 participants4 studies pooledBrain Health Productivity Boost forGinkgo
  8. Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
    Cui M; You T; Zhao Y; Liu R; Guan Y; Liu J; Liu X; Wang X; Dong Q · Frontiers in pharmacology · 2023
    Randomized trial201 participantsBrain Health Productivity Boost forGinkgo
  9. Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
    Herrschaft H; Nacu A; Likhachev S; Sholomov I; Hoerr R; Schlaefke S · Journal of psychiatric research · 2012
    Randomized trial410 participantsBrain Health forGinkgo
  10. Combination of Vinpocetine and Dexamethasone Alleviates Cognitive Impairment in Nasopharyngeal Carcinoma Patients following Radiation Injury.
    Zhang P; Cao Y; Chen S; Shao L · Pharmacology · 2021
    Randomized trial60 participantsBrain Health forVinpocetine
  11. Effects of vinpocetine on the redistribution of cerebral blood flow and glucose metabolism in chronic ischemic stroke patients: a PET study.
    Szilágyi G; Nagy Z; Balkay L; Boros I; Emri M; Lehel S; Márián T; Molnár T; Szakáll S; Trón L; Bereczki D; Csiba L; Fekete I; Kerényi L; Galuska L; Varga J; Bönöczk P; Vas A; Gulyás B · Journal of the neurological sciences · 2005
    Randomized trial13 participantsBrain Health forVinpocetine
  12. Role of sodium channel inhibition in neuroprotection: effect of vinpocetine.
    Bönöczk P; Gulyás B; Adam-Vizi V; Nemes A; Kárpáti E; Kiss B; Kapás M; Szántay C; Koncz I; Zelles T; Vas A · Brain research bulletin · 2001
    Narrative reviewBrain Health forVinpocetine
  13. [Study of the effects of vinpocetin on cognitive functions].
    Valikovics A; Csányi A; Németh L · Ideggyogyaszati szemle · 2012
    Clinical trialBrain Health forVinpocetine
  14. Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review.
    Hort J; Duning T; Hoerr R · Neuropsychiatric disease and treatment · 2023
    Systematic review946 participants9 studies pooledMental Focus forGinkgo
  15. Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2012
    Randomized trial216 participantsMental Focus forGinkgo
  16. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Pharmacopsychiatry · 1996
    Randomized trial216 participantsMental Focus forGinkgo
  17. Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial.
    Li S; Zhang X; Fang Q; Zhou J; Zhang M; Wang H; Chen Y; Xu B; Wu Y; Qian L; Xu Y · Stroke and vascular neurology · 2021
    Randomized trial348 participantsMental Focus forGinkgo
  18. Ginkgo biloba in the Aging Process: A Narrative Review.
    Barbalho SM; Direito R; Laurindo LF; Marton LT; Guiguer EL; Goulart RA; Tofano RJ; Carvalho ACA; Flato UAP; Capelluppi Tofano VA; Detregiachi CRP; Bueno PCS; Girio RSJ; Araújo AC · Antioxidants (Basel, Switzerland) · 2024
    Narrative review14 studies pooledMental Focus forGinkgo
  19. "Brain-specific" nutrients: a memory cure?
    McDaniel MA; Maier SF; Einstein GO · Nutrition (Burbank, Los Angeles County, Calif.) · 2004
    Narrative reviewMental Focus forVinpocetine
  20. [Ginkgo biloba extract EGb 761 in the treatment of dementia: evidence of efficacy and tolerability].
    Kasper S; Schubert H · Fortschritte der Neurologie-Psychiatrie · 2009
    Meta-analysis10 studies pooledProductivity Boost forGinkgo
  21. Dietary Flavonoids and Human Cognition: A Meta-Analysis.
    Cheng N; Bell L; Lamport DJ; Williams CM · Molecular nutrition & food research · 2022
    Meta-analysis5,519 participants80 studies pooledProductivity Boost forGinkgo
  22. Limited cognitive benefits in Stage +2 postmenopausal women after 6 weeks of treatment with Ginkgo biloba.
    Elsabagh S; Hartley DE; File SE · Journal of psychopharmacology (Oxford, England) · 2005
    Randomized trial87 participantsProductivity Boost forGinkgo
  23. Efficacy and safety of Ginkgo biloba extract EGb 761 in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo-controlled, double-blind, multi-center trial.
    Gavrilova SI; Preuss UW; Wong JW; Hoerr R; Kaschel R; Bachinskaya N; GIMCIPlus Study Group · International journal of geriatric psychiatry · 2015
    Randomized trial160 participantsProductivity Boost forGinkgo
  24. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
    Le Bars PL; Katz MM; Berman N; Itil TM; Freedman AM; Schatzberg AF · JAMA · 1997
    Randomized trial309 participantsProductivity Boost forGinkgo
  25. Modulation of cognitive performance following single doses of 120 mg Ginkgo biloba extract administered to healthy young volunteers.
    Kennedy DO; Jackson PA; Haskell CF; Scholey AB · Human psychopharmacology · 2008
    Randomized trial78 participantsProductivity Boost forGinkgo
  26. Effect of Ginkgo biloba extracts in the prevention of posterior capsule opacification after cataract surgery: A randomized clinical trial.
    Amiri AA; Jafari R; Amiri AA; Rad HA; Daneshvar F; Charati JY; Amiri AA · Oman journal of ophthalmology · 2025
    Randomized trial144 participantsVision Support forGinkgo
  27. Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma.
    Quaranta L; Bettelli S; Uva MG; Semeraro F; Turano R; Gandolfo E · Ophthalmology · 2003
    Randomized trial27 participantsVision Support forGinkgo
  28. [Ginkgo extract in impaired vision--treatment with special extract EGb 761 of impaired vision due to dry senile macular degeneration].
    Fies P; Dienel A · Wiener medizinische Wochenschrift (1946) · 2002
    Randomized trial99 participantsVision Support forGinkgo
  29. Short-term effects of Ginkgo biloba extract on peripapillary retinal blood flow in normal tension glaucoma.
    Park JW; Kwon HJ; Chung WS; Kim CY; Seong GJ · Korean journal of ophthalmology : KJO · 2012
    Randomized trial30 participantsVision Support forGinkgo
  30. [The course of color vision in early diabetic retinopathy treated with Ginkgo biloba extract. A preliminary double-blind versus placebo study].
    Lanthony P; Cosson JP · Journal francais d'ophtalmologie · 1989
    Randomized trial29 participantsVision Support forGinkgo
  31. [Effect of vasoactive agents on visual functions and ocular blood flow in patients with early manifestations of age-related macular degeneration].
    Avetisov SE; Kiseleva TN; Lagutina IuM; Kravchuk EA · Vestnik oftalmologii · 2007
    Non-randomized trial40 participantsVision Support forVinpocetine